Genetic findings in a patient with paradoxical pyoderma gangrenosum induced by brodalumab
Clin Exp Dermatol
.
2023 Mar 1;48(3):293-295.
doi: 10.1093/ced/llac117.
Authors
Italo Francesco Aromolo
1
2
,
Carlo Alberto Maronese
1
2
,
Chiara Moltrasio
1
3
,
Francesca Boggio
4
,
Silvia Alberti Violetti
2
,
Gianluca Avallone
1
2
5
,
Nicole Morini
1
2
,
Carlo Giovanni Carrera
1
,
Giovanni Genovese
1
,
Angelo Valerio Marzano
1
2
Affiliations
1
Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
2
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
3
Department of Medical Surgical and Health Sciences, University of Trieste, Trieste, Italy.
4
Pathology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
5
Department of Medical Sciences, Dermatology Clinic, University of Turin, Turin, Italy.
PMID:
36763724
DOI:
10.1093/ced/llac117
No abstract available
MeSH terms
Antibodies, Monoclonal, Humanized
Humans
Pyoderma Gangrenosum*
Substances
brodalumab
Antibodies, Monoclonal, Humanized